Reuters logo
BRIEF-U.S. FDA says Magellan Diagnostics expands recall for leadcare testing systems ‍​
June 5, 2017 / 9:37 PM / 5 months ago

BRIEF-U.S. FDA says Magellan Diagnostics expands recall for leadcare testing systems ‍​

June 5 (Reuters) -

* U.S. FDA says Magellan Diagnostics expands recall for leadcare testing systems due to inaccurate test results ‍​

* U.S. FDA says Magellan Diagnostics expands recall for leadcare and leadcare ii blood lead testing systems to 7.1 million devices‍​

* U.S. FDA says Magellan Diagnostics expands leadcare plus and ultra testing systems recall to include two additional testing systems

* U.S. FDA says has identified Magellan Diagnostics' recall as a class i recall, the most serious type of recall Source text -bit.ly/2swUCb7

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below